Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Current Opinion in Biotechnology
|
October 28, 2020
Virus-induced metabolic reprogramming and innate sensing hereof by the infected host
Jacob Thyrsted, Christian Kanstrup Holm
Antioxidants (Basel, Switzerland)
|
September 28, 2021
NRF2 in Viral Infection
Angela Herengt, Jacob Thyrsted, Christian K Holm
Antiviral Research
|
November 28, 2020
Ionophore antibiotic X-206 is a potent inhibitor of SARS-CoV-2 infection in vitro
Esben B Svenningsen, Jacob Thyrsted, Julia Blay-Cadanet, et al.
Iscience
|
November 8, 2021
Influenza A induces lactate formation to inhibit type I IFN in primary human airway epithelium
Jacob Thyrsted, Jacob Storgaard, Julia Blay-Cadanet, et al.
EMBO Reports
|
October 28, 2020
SARS-CoV-2 evades immune detection in alveolar macrophages
Louise Dalskov, Michelle Møhlenberg, Jacob Thyrsted, et al.
Infection Control and Hospital Epidemiology
|
April 3, 2025
Ceiling-mounted far-UVC fixtures reduce the surface bioburden in occupied clinical areas
Emilie Hage Mogensen, Jacob Thyrsted Jensen, Søren Helbo Skaarup, et al.
Redox Biology
|
April 3, 2026
NRF2 controls a diverse network of antiviral effectors with p62 acting as a central restriction factor effective across virus families
Alice Pedersen, Julia Blay-Cadanet, Jacob Storgaard, et al.
Nature Communications
|
February 9, 2024
Amyloid-β aggregates activate peripheral monocytes in mild cognitive impairment
Kristian Juul-Madsen, Peter Parbo, Rola Ismail, et al.
The EMBO Journal
|
February 18, 2022
TLR2 and TLR7 mediate distinct immunopathological and antiviral plasmacytoid dendritic cell responses to SARS-CoV-2 infection
Renée M van der Sluis, Lamin B Cham, Albert Gris-Oliver, et al.
Nature Communications
|
August 31, 2018
Nrf2 negatively regulates STING indicating a link between antiviral sensing and metabolic reprogramming
David Olagnier, Aske M Brandtoft, Camilla Gunderstofte, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Current Opinion in Biotechnology
|
October 28, 2020
Virus-induced metabolic reprogramming and innate sensing hereof by the infected host
Jacob Thyrsted, Christian Kanstrup Holm
Antioxidants (Basel, Switzerland)
|
September 28, 2021
NRF2 in Viral Infection
Angela Herengt, Jacob Thyrsted, Christian K Holm
Antiviral Research
|
November 28, 2020
Ionophore antibiotic X-206 is a potent inhibitor of SARS-CoV-2 infection in vitro
Esben B Svenningsen, Jacob Thyrsted, Julia Blay-Cadanet, et al.
Iscience
|
November 8, 2021
Influenza A induces lactate formation to inhibit type I IFN in primary human airway epithelium
Jacob Thyrsted, Jacob Storgaard, Julia Blay-Cadanet, et al.
EMBO Reports
|
October 28, 2020
SARS-CoV-2 evades immune detection in alveolar macrophages
Louise Dalskov, Michelle Møhlenberg, Jacob Thyrsted, et al.
Infection Control and Hospital Epidemiology
|
April 3, 2025
Ceiling-mounted far-UVC fixtures reduce the surface bioburden in occupied clinical areas
Emilie Hage Mogensen, Jacob Thyrsted Jensen, Søren Helbo Skaarup, et al.
Redox Biology
|
April 3, 2026
NRF2 controls a diverse network of antiviral effectors with p62 acting as a central restriction factor effective across virus families
Alice Pedersen, Julia Blay-Cadanet, Jacob Storgaard, et al.
Nature Communications
|
February 9, 2024
Amyloid-β aggregates activate peripheral monocytes in mild cognitive impairment
Kristian Juul-Madsen, Peter Parbo, Rola Ismail, et al.
The EMBO Journal
|
February 18, 2022
TLR2 and TLR7 mediate distinct immunopathological and antiviral plasmacytoid dendritic cell responses to SARS-CoV-2 infection
Renée M van der Sluis, Lamin B Cham, Albert Gris-Oliver, et al.
Nature Communications
|
August 31, 2018
Nrf2 negatively regulates STING indicating a link between antiviral sensing and metabolic reprogramming
David Olagnier, Aske M Brandtoft, Camilla Gunderstofte, et al.
Page
of 2